Patients with the Subcortical Small Vessel Type of Dementia Have Disturbed Cardiometabolic Risk Profile

Elin Axelsson1, Anders Wallin2, Johan Svensson1

  • 1Department of Internal Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Insights

Subcortical small vessel dementia (SSVD) patients have distinct cardiometabolic risk factors, including higher rates of hypertension and diabetes, and lower cholesterol levels compared to controls. These findings highlight unique risk profiles in dementia subtypes.

Area of Science:

  • Neurology
  • Cardiology
  • Gerontology

Background:

  • Cardiometabolic status is linked to white matter hyperintensities (WMHs) on MRI.
  • WMHs are a key feature of subcortical small vessel dementia (SSVD).
  • Limited data exists on cardiometabolic risk factors specifically in SSVD.

Purpose of the Study:

  • To compare cardiometabolic risk factor profiles across SSVD, Alzheimer's disease (AD), mixed dementia, and healthy controls.
  • To identify specific risk factors associated with SSVD.

Main Methods:

  • A cross-sectional study involving 40 SSVD patients, 113 AD patients, 62 mixed dementia patients, and 94 healthy controls.
  • Statistical analyses included ANCOVA and binary logistic regression, adjusting for covariates.

Main Results:

  • Hypertension was more prevalent in SSVD and mixed dementia groups compared to controls.
  • Diabetes was more common in SSVD patients; lower BMI was observed in AD and mixed dementia groups.
  • SSVD patients had reduced serum total cholesterol (TC) and low-density lipoprotein-cholesterol (LDL-C).

Conclusions:

  • All dementia groups exhibited altered cardiometabolic risk profiles compared to controls.
  • SSVD is characterized by increased hypertension and diabetes prevalence, with reduced serum TC and LDL-C.
  • Cognitive performance in SSVD correlated with blood pressure measures.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
805
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
280
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
459
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.7K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
256
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
715